by Megan Pullins | Jun 11, 2018 | Pharmacy, Primary Care
The first migraine prevention medication was approved by the FDA in May, 2018. Pharmaceutical companies Amgen and Novartis designed the CGRP receptor blocking monthly injection Aimovig (erenumab-aooe) as a game changer for those who suffer from migraines. Aimovig is...
